Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent lawsuits
Pharma
Appeals court backs Regeneron's antitrust suit against Novartis
Novartis and Vetter must now defend against Regeneron's allegation that the companies conspired to delay a prefilled syringe version of Eylea.
Angus Liu
Mar 19, 2024 10:40am
Roche, Biogen settle Actemra biosimilar lawsuit
Oct 25, 2023 10:20am
BMS, AZ settle cancer immunotherapy patent suits for $510M
Aug 1, 2023 10:09am
Shionogi, Takeda, AbbVie-BeiGene—Fierce Pharma Asia
Jun 30, 2023 9:45am
AbbVie's Imbruvica-Brukinsa patent suit may have merit: expert
Jun 27, 2023 10:48am
Astellas, Eisai and BeiGene—Fierce Pharma Asia
Jun 16, 2023 8:30am